These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 17664021)

  • 1. Genetic deletion of vesicular monoamine transporter-2 (VMAT2) reduces dopamine transporter activity in mesencephalic neurons in primary culture.
    Yamamoto H; Kamegaya E; Hagino Y; Imai K; Fujikawa A; Tamura K; Enokiya T; Yamamoto T; Takeshima T; Koga H; Uhl GR; Ikeda K; Sora I
    Neurochem Int; 2007; 51(2-4):237-44. PubMed ID: 17664021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons.
    Liang CL; Nelson O; Yazdani U; Pasbakhsh P; German DC
    J Comp Neurol; 2004 May; 473(1):97-106. PubMed ID: 15067721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice.
    Patel J; Mooslehner KA; Chan PM; Emson PC; Stamford JA
    J Neurochem; 2003 May; 85(4):898-910. PubMed ID: 12716422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of membrane and vesicular monoamine transporters in the neurotoxic and hypothermic effects of 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH(2)-MPTP).
    Numis AL; Unger EL; Sheridan DL; Chisnell AC; Andrews AM
    Mol Pharmacol; 2004 Sep; 66(3):718-27. PubMed ID: 15322265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurochemical investigations of dopamine neuronal systems in iron-regulatory protein 2 (IRP-2) knockout mice.
    Salvatore MF; Fisher B; Surgener SP; Gerhardt GA; Rouault T
    Brain Res Mol Brain Res; 2005 Oct; 139(2):341-7. PubMed ID: 16051392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine transporter and vesicular monoamine transporter knockout mice : implications for Parkinson's disease.
    Miller GW; Wang YM; Gainetdinov RR; Caron MG
    Methods Mol Med; 2001; 62():179-90. PubMed ID: 21318776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of dopaminergic cell markers in the adult zebrafish forebrain.
    Yamamoto K; Ruuskanen JO; Wullimann MF; Vernier P
    J Comp Neurol; 2011 Feb; 519(3):576-98. PubMed ID: 21192085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of dopaminergic neurons in organotypic mesencephalic-striatal co-cultures--evidence for a facilitatory effect of dopamine on the glutamatergic input mediated by α-1 adrenergic receptors.
    Cucchiaroni ML; Freestone PS; Berretta N; Viscomi MT; Bisicchia E; Okano H; Molinari M; Bernardi G; Lipski J; Mercuri NB; Guatteo E
    Eur J Neurosci; 2011 May; 33(9):1622-36. PubMed ID: 21453288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anatomical and functional reconstruction of the nigrostriatal pathway by intranigral transplants.
    Gaillard A; Decressac M; Frappé I; Fernagut PO; Prestoz L; Besnard S; Jaber M
    Neurobiol Dis; 2009 Sep; 35(3):477-88. PubMed ID: 19616502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of VMAT2 in dopaminergic neurons during nicotine withdrawal.
    Duchemin AM; Zhang H; Neff NH; Hadjiconstantinou M
    Neurosci Lett; 2009 Dec; 467(2):182-6. PubMed ID: 19835933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid regulation of dopamine transporters by tyrosine kinases in rat neuronal preparations.
    Hoover BR; Everett CV; Sorkin A; Zahniser NR
    J Neurochem; 2007 Jun; 101(5):1258-71. PubMed ID: 17419806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) function in knockout mice affects aging of dopaminergic systems.
    Hall FS; Itokawa K; Schmitt A; Moessner R; Sora I; Lesch KP; Uhl GR
    Neuropharmacology; 2014 Jan; 76 Pt A(0 0):146-55. PubMed ID: 23978383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of functional dopaminergic phenotype in purified cultured Müller cells from vertebrate retina.
    Kubrusly RC; Panizzutti R; Gardino PF; Stutz B; Reis RA; Ventura AL; de Mello MC; de Mello FG
    Neurochem Int; 2008 Sep; 53(3-4):63-70. PubMed ID: 18582514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine transporter as a target molecule for psychostimulants.
    Sora I; Li B; Fumushima S; Fukui A; Arime Y; Kasahara Y; Tomita H; Ikeda K
    Int Rev Neurobiol; 2009; 85():29-33. PubMed ID: 19607959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization and dynamic regulation of biogenic amine transporters in the mammalian central nervous system.
    Hoffman BJ; Hansson SR; Mezey E; Palkovits M
    Front Neuroendocrinol; 1998 Jul; 19(3):187-231. PubMed ID: 9665836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro analysis of Pitx3 in mesodiencephalic dopaminergic neuron maturation.
    Papanikolaou T; Amano T; Lennington J; Sink K; Farrar AM; Salamone J; Yang X; Conover JC
    Eur J Neurosci; 2009 Jun; 29(12):2264-75. PubMed ID: 19508691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity-dependent regulation of the dopamine transporter is mediated by Ca(2+)/calmodulin-dependent protein kinase signaling.
    Padmanabhan S; Lambert NA; Prasad BM
    Eur J Neurosci; 2008 Nov; 28(10):2017-27. PubMed ID: 19046383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Episodic-like and procedural memory impairments in histamine H1 Receptor knockout mice coincide with changes in acetylcholine esterase activity in the hippocampus and dopamine turnover in the cerebellum.
    Dere E; Zlomuzica A; Viggiano D; Ruocco LA; Watanabe T; Sadile AG; Huston JP; De Souza-Silva MA
    Neuroscience; 2008 Dec; 157(3):532-41. PubMed ID: 18926883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced expression and capacity of the striatal high-affinity choline transporter in hyperdopaminergic mice.
    Parikh V; Apparsundaram S; Kozak R; Richards JB; Sarter M
    Neuroscience; 2006 Aug; 141(1):379-89. PubMed ID: 16675138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of TH-EGFP transgenic mice as a source of identified dopaminergic neurons for physiological studies in postnatal cell culture.
    Jomphe C; Bourque MJ; Fortin GD; St-Gelais F; Okano H; Kobayashi K; Trudeau LE
    J Neurosci Methods; 2005 Jul; 146(1):1-12. PubMed ID: 15935217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.